Abstract: A video map engine system includes a configuration management client, multiple video equipments, a video access server, an augmented reality processor, and an augmented reality client. The parameters of the video equipments includes azimuth angle P, vertical angle T and zoom factor Z of the video equipment, the augmented reality client is adapted for calculating the location where the augmented reality tag is presented in the real-time video according to the values of P, T, Z and the target location carried by the augmented reality tag, and presenting the augmented reality tag on the corresponding location of the real-time video. Therefore, the real-time video is served as the base map, and the augmented reality tag is presented on the base map, thereby achieving a video map effect.

Abstract: A sensor calibrator comprising one or more processors configured to receive sensor data representing a calibration pattern detected by a sensor during a period of relative motion between the sensor and the calibration pattern in which the sensor or the calibration pattern move along a linear path of travel; determine a calibration adjustment from the plurality of images; and send a calibration instruction for calibration of the sensor according to the determined calibration adjustment. Alternatively, a sensor calibration detection device, comprising one or more processors, configured to receive first sensor data detected during movement of a first sensor along a route of travel; determine a difference between the first sensor data and stored second sensor data; and if the difference is outside of a predetermined range, switch from a first operational mode to a second operational mode.

Abstract: The present disclosure is directed to a cleavable agent for enhanced magnetic resonance generally corresponding to the formula Y-L-R, wherein Y represents a catalyst-binding moiety having at least one isotopically labeled heteroatom, L represents a cleavable bond, and R represents a hyperpolarized payload having at least one isotopically labeled carbon. Also disclosed herein is a method of cleaving the cleavable agent for enhanced magnetic resonance.

Abstract: Described herein are systems and methods for providing deeply stacked automated program synthesis. In one embodiment, an apparatus to perform automated program synthesis includes a memory to store instructions for automated program synthesis and a compute cluster coupled to the memory. The compute cluster supports the instructions for performing the automated program synthesis including partitioning sketched data into partitions, training diverse sets of individual program synthesis units each having different capabilities with partitioned sketched data and for each partition applying respective transformations, and generating sketched baseline data for each individual program synthesis unit.

Abstract: Methods and systems for budgeted and simplified training of deep neural networks (DNNs) are disclosed. In one example, a trainer is to train a DNN using a plurality of training sub-images derived from a down-sampled training image. A tester is to test the trained DNN using a plurality of testing sub-images derived from a down-sampled testing image. In another example, in a recurrent deep Q-network (RDQN) having a local attention mechanism located between a convolutional neural network (CNN) and a long-short time memory (LSTM), a plurality of feature maps are generated by the CNN from an input image. Hard-attention is applied by the local attention mechanism to the generated plurality of feature maps by selecting a subset of the generated feature maps. Soft attention is applied by the local attention mechanism to the selected subset of generated feature maps by providing weights to the selected subset of generated feature maps in obtaining weighted feature maps.

Abstract: Provided are methods employing estrogenic compounds for: repressing weight gain or reducing weight in male patients; treating or preventing prostate cancer and peri- or post-menopausal symptoms; treating estrogen-responsive conditions that no longer respond to treatment with conventional steroidal estrogens; treating or preventing estrogen-responsive uterine cancer, breast cancer, and ovarian follicle atresia; inducing ovulation to increase fertility; oral contraception; treating or preventing diseases or conditions caused or prolonged by free radicals; treating or preventing cardiovascular disease, hyperlipidemia or hypercholesterolemia, and hyperglycemia; improving body fat distribution; and treating or preventing Alzheimer's disease, osteoporosis, and pattern baldness.

Abstract: Provided is a method comprising administering (+) -Z- bisdehydrodoisynolic acid to a patient for treating, inhibiting or delaying the onset of prostatic conditions including prostatitis, benign prostatic hypertrophy and prostate cancer without accompanying feminizing effects.